Search by Drug Name or NDC
NDC 50090-4236-00 Atomoxetine Hydrochloride 40 mg/1 Details
Atomoxetine Hydrochloride 40 mg/1
Atomoxetine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is ATOMOXETINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.
Related Packages: 50090-4236-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Atomoxetine
Product Information
NDC | 50090-4236 |
---|---|
Product ID | 50090-4236_d1a130e7-3cee-40cf-a4c6-cb3893304987 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Atomoxetine Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | atomoxetine hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 40 |
Active Ingredient Units | mg/1 |
Substance Name | ATOMOXETINE HYDROCHLORIDE |
Labeler Name | A-S Medication Solutions |
Pharmaceutical Class | Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078983 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4236-00 (50090423600)
NDC Package Code | 50090-4236-0 |
---|---|
Billing NDC | 50090423600 |
Package | 30 CAPSULE in 1 BOTTLE (50090-4236-0) |
Marketing Start Date | 2019-03-29 |
NDC Exclude Flag | N |
Pricing Information | N/A |